
CAS 1173699-31-4
:Formula:C23H22FN7O3
InChI:InChI=1S/C23H22FN7O3/c1-14(30-5-4-20-18(23(30)32)9-17(11-25-20)34-7-6-33-3)21-27-28-22-19(24)8-15(13-31(21)22)16-10-26-29(2)12-16/h4-5,8-14H,6-7H2,1-3H3/t14-/m1/s1
InChI key:DWHXUGDWKAIASB-CQSZACIVSA-N
SMILES:C[C@H](C1=NN=C2N1C=C(C=C2F)C3=CN(N=C3)C)N4C=CC5=C(C4=O)C=C(C=N5)OCCOC
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
6-[(1R)-1-[8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one
CAS:Formula:C23H22FN7O3Purity:%Color and Shape:SolidMolecular weight:463.4643(R)-6-(1-(8-Fluoro-6-(1-Methyl-1H-Pyrazol-4-Yl)-[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl)Ethyl)-3-(2-Methoxyethoxy)-1,6-Naphthyridin-5(6H)-One
CAS:(R)-6-(1-(8-Fluoro-6-(1-Methyl-1H-Pyrazol-4-Yl)-[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl)Ethyl)-3-(2-Methoxyethoxy)-1,6-Naphthyridin-5(6H)-OneFormula:C23H22FN7O3Purity:98+%Molecular weight:463.46AMG-337
CAS:AMG-337 is an effective and highly specific ATP-competitive MET kinase inhibitor. In enzymatic assays, AMG-337 inhibits MET kinase activity (IC50: < 5 nM).Formula:C23H22FN7O3Purity:99.26% - 99.9%Color and Shape:White SolidMolecular weight:463.46Ref: TM-T3209
1mg38.00€2mg50.00€5mg80.00€1mL*10mM (DMSO)81.00€10mg117.00€25mg187.00€50mg333.00€100mg495.00€200mg710.00€AMG-337
CAS:(R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-oneFormula:C23H22FN7O3Purity:98+%Molecular weight:463.46AMG 337
CAS:Controlled ProductApplications AMG 337 is a potent and selective inhibitor of mesencymal epethelial transition factor (MET factor) which has been implicated in several cancers.
References Boezio, A. et al.: J. Med. Chem., 59, 2326 (2016);Formula:C23H22FN7O3Color and Shape:NeatMolecular weight:463.46AMG 337
CAS:AMG 337 is a small molecule inhibitor, which is derived from synthetic chemical processes, with a mode of action involving the selective inhibition of the c-Met receptor tyrosine kinase. The c-Met receptor, also known as hepatocyte growth factor receptor, plays a critical role in various cellular processes such as proliferation, survival, and motility. Dysregulation of c-Met signaling is implicated in several types of cancers, making it a significant therapeutic target.Formula:C23H22FN7O3Purity:Min. 95%Molecular weight:463.46 g/mol





